S. Špánik

2.5k total citations
79 papers, 1.4k citations indexed

About

S. Špánik is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, S. Špánik has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 20 papers in Infectious Diseases and 19 papers in Surgery. Recurrent topics in S. Špánik's work include Neutropenia and Cancer Infections (29 papers), Antifungal resistance and susceptibility (15 papers) and Cancer Treatment and Pharmacology (15 papers). S. Špánik is often cited by papers focused on Neutropenia and Cancer Infections (29 papers), Antifungal resistance and susceptibility (15 papers) and Cancer Treatment and Pharmacology (15 papers). S. Špánik collaborates with scholars based in Slovakia, India and Malaysia. S. Špánik's co-authors include V. Krčméry, J. Trupl, Jozef Mardiak, A. Kunová, Daniela Světlovská, Michal Mego, Michal Chovanec, Katarína Rejleková, Věra Miškovská and E. Kukučková and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

S. Špánik

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Špánik Slovakia 20 556 382 337 325 279 79 1.4k
Marcus Gorschlüter Germany 20 910 1.6× 391 1.0× 486 1.4× 190 0.6× 250 0.9× 44 1.6k
Tsiporah B. Shore United States 27 919 1.7× 345 0.9× 516 1.5× 114 0.4× 252 0.9× 152 2.3k
Patricia García Chile 22 370 0.7× 145 0.4× 307 0.9× 508 1.6× 249 0.9× 77 1.7k
Simon Daenen Netherlands 29 695 1.3× 462 1.2× 563 1.7× 86 0.3× 153 0.5× 78 2.5k
Carola Arndt United States 23 753 1.4× 820 2.1× 743 2.2× 308 0.9× 699 2.5× 41 2.5k
Kei Suzuki Japan 19 411 0.7× 267 0.7× 319 0.9× 241 0.7× 479 1.7× 119 1.5k
J F Silverman United States 21 295 0.5× 152 0.4× 364 1.1× 411 1.3× 305 1.1× 41 1.3k
Hamdi Akan Türkiye 26 555 1.0× 602 1.6× 775 2.3× 136 0.4× 131 0.5× 106 1.8k
Masahiko Okudaira Japan 18 333 0.6× 589 1.5× 1.0k 3.1× 421 1.3× 180 0.6× 105 1.9k
Akiko Yoneyama Japan 22 228 0.4× 288 0.8× 345 1.0× 266 0.8× 85 0.3× 82 1.4k

Countries citing papers authored by S. Špánik

Since Specialization
Citations

This map shows the geographic impact of S. Špánik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Špánik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Špánik more than expected).

Fields of papers citing papers by S. Špánik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Špánik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Špánik. The network helps show where S. Špánik may publish in the future.

Co-authorship network of co-authors of S. Špánik

This figure shows the co-authorship network connecting the top 25 collaborators of S. Špánik. A scholar is included among the top collaborators of S. Špánik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Špánik. S. Špánik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chovanec, Michal, Zuzana Čierna, Katarína Macháleková, et al.. (2018). βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors. BMC Cancer. 18(1). 1062–1062. 19 indexed citations
2.
Kaľavská, Katarína, Zuzana Čierna, Michal Chovanec, et al.. (2017). Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors. Oncology Letters. 13(4). 2177–2185. 14 indexed citations
3.
Kaľavská, Katarína, Michal Chovanec, Miriam Zaťovičová, et al.. (2016). Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients. Oncology Letters. 12(4). 2590–2598. 6 indexed citations
4.
Mego, Michal, Jozef Chovanec, Mária Rečková, et al.. (2015). Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine. 23(3). 356–362. 180 indexed citations
5.
Mego, Michal, Daniela Světlovská, Věra Miškovská, et al.. (2015). Phase II study of everolimus in refractory testicular germ cell tumors. Urologic Oncology Seminars and Original Investigations. 34(3). 122.e17–122.e22. 42 indexed citations
6.
Špánik, S., et al.. (2015). TREATMENT OF METASTATIC HEAD AND NECK CANCER WITH MESENCHYMAL STEM CELLS COMBINED WITH PRODRUG GENE THERAPY. Experimental Oncology. 37(4). 298–298. 4 indexed citations
7.
Brodowicz, Thomas, István Láng, Zsuzsanna Kahán, et al.. (2014). Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. British Journal of Cancer. 111(11). 2051–2057. 24 indexed citations
8.
Sabol, Martin, et al.. (2014). Surgical Treatment of Metastases and its Impact on Prognosis in Patients with Metastatic Colorectal Carcinoma. Klinicka onkologie. 27(1). 38–44. 3 indexed citations
9.
Kahán, Zsuzsanna, S. Špánik, M Wagnerová, et al.. (2010). Health-related quality of life (HQOL) and early survival outcome of the randomized adjuvant dose-dense (dd) FEC75 versus FEC90 CECOG study.. Journal of Clinical Oncology. 28(15_suppl). e11058–e11058. 1 indexed citations
10.
Krčméry, V., S. Špánik, A. Kunová, & J. Trupl. (1997). Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B. Chemotherapy. 43(5). 367–370. 11 indexed citations
11.
Krčméry, V., et al.. (1997). Bacteremia in Cancer Patients with Solid Tumors Undergoing Chemotherapy versus Surgery: Risk Factors, Etiology and Outcome in 276 Patients. Journal of Chemotherapy. 9(3). 232–237. 2 indexed citations
12.
Kunová, A., J. Trupl, Zdenka Jesenská, et al.. (1997). Eight-Year Surveillance of Non-Albicans Candida spp . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis. Microbial Drug Resistance. 3(3). 283–287. 11 indexed citations
13.
Špánik, S., et al.. (1997). Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?. Journal of Chemotherapy. 9(6). 420–426. 33 indexed citations
14.
Kukučková, E., S. Špánik, E. Oravcová, et al.. (1996). Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Supportive Care in Cancer. 4(6). 427–434. 3 indexed citations
15.
Špánik, S., et al.. (1996). Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.. PubMed. 43(4). 235–8. 11 indexed citations
16.
Špánik, S., J. Trupl, Ľuboš Drgoňa, et al.. (1996). Bacteremia and Fungemia Occurring during Antimicrobial Prophylaxis with Ofloxacin in Cancer Patients: Risk Factors, Etiology and Outcome. Journal of Chemotherapy. 8(5). 387–393. 3 indexed citations
17.
Oravcová, E., E. Kukučková, V. Krčméry, et al.. (1996). Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients. Infection. 24(4). 319–323. 18 indexed citations
18.
Trupl, J., et al.. (1995). Nosocomial bacterial and fungal meningitis in cancer patients. Supportive Care in Cancer. 3(6). 425–427. 5 indexed citations
19.
20.
Krčméry, V., I Koza, Jozef Mardiak, et al.. (1992). Netilmicin plus Ceftriaxone versus Amikacin plus Ceftriaxone in the Treatment of Infections in Granulocytopenic Patients. Chemotherapy. 38(1). 74–76. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Gorschlüter Breakdown of academic impact, for papers by Tsiporah B. Shore Breakdown of academic impact, for papers by Patricia García Breakdown of academic impact, for papers by Simon Daenen Breakdown of academic impact, for papers by Carola Arndt Breakdown of academic impact, for papers by Kei Suzuki Breakdown of academic impact, for papers by J F Silverman Breakdown of academic impact, for papers by Hamdi Akan Breakdown of academic impact, for papers by Masahiko Okudaira Breakdown of academic impact, for papers by Akiko Yoneyama
Rankless by CCL
2026